New Canine Study From Belhaven Biopharma Supports Dry Powder Nasal Epinephrine Delivery Solution

July 9, 2024 11:00 AM

Presented at Respiratory Drug Delivery 2024, the Nasdepi Canine Study Indicates the Dry Powder Nasal Solution Provides a Faster and More Effective Treatment for Anaphylaxis as a Result of Severe AllergiesRALEIGH, NC / ACCESSWIRE / July 9, 2024 / Belhaven Biopharma, a leader in emergency use dry powder nasal products, announces the promising results of their latest nonclinical study comparing the pharmacokinetics of dry powder nasal epinephrine...

Read more

Advanced Fertility Center of Texas Has Been Awarded on the Newsweek List of America’s Best Fertility Clinics 2024; Awarded #1 in Texas and #7 Nationwide

July 9, 2024 10:00 AM

Advanced Fertility Center of Texas (AFCT) is proud to announce that it has been recognized on Newsweek and Statista Inc.'s list of America's Best Fertility Clinics 2024HOUSTON, TX / ACCESSWIRE / July 9, 2024 / Newsweek and Statista Inc., the world-leading statistics portal and industry ranking provider, presents this prestigious award. The evaluation of fertility clinics was based on four pillars: Newsweek Logo Nationwide Online Survey:...

Read more

Mentavi Health Expands Diagnostic Evaluation Approach to Address Broader Range of Mental Health Conditions

July 9, 2024 9:45 AM

Comprehensive online evaluation and dynamic questionnaire backed by clinical psychologists enable accurate mental health diagnosis and treatment.GRAND RAPIDS, MI / ACCESSWIRE / July 9, 2024 / Mentavi Health has launched a new chapter in the pioneering telehealth company's history with a major expansion of its online mental health assessment. The innovations enable the diagnosis of a broader spectrum of mental health conditions and refine...

Read more

Skinvisible Unveils Promising Data on Transdermal Obesity Formulations

July 9, 2024 9:00 AM

Skinvisible Pharmaceuticals, Inc. ("Skinvisible" or "the Company"), (OTCQB:SKVI), an innovative topical pharmaceutical research and development company, today announced exciting data demonstrating its transdermal delivery of obesity drugs (and other glucose- controlling drugs) including a GLP-1 agonist and CB-1 receptor antagonist delivered by its proprietary Invisicare® technology; a polymer delivery vehicle that does not require a patch or...

Read more

Ludwig Enterprises Files Provisional Patent on mRNA Genetic Screening Signals in Breast, Colon and Bladder Cancer

July 9, 2024 8:00 AM

Ludwig Enterprises, Inc, (OTC PINK:LUDG), a USA based biotechnology company is pleased to announce that the company has filed a provisional patent titled "mRNAs DIFFERENTIALLY EXPRESSED IN COLORECTAL CANCER, BREAST CANCER, AND BLADDER CANCER." The present invention generally relates to the use of mRNA genetic transcripts to (a) identify and differentiate between cancers, and (b) determine the effectiveness of a treatment for a cancer.The mRNA...

Read more

Hop on a Cure Makes Financial Contribution Toward ALS CURE Project

July 9, 2024 8:00 AM

ATLANTA, GA / ACCESSWIRE / July 9, 2024 / Hop On A Cure, a leading advocate in the fight against ALS, has announced today their financial contribution to ALS CURE Project - specifically toward the organization's 3ML Project, which was created to develop a multi-modal longitudinal ML/statistical model that analyzes ALS patient's biometrics differences longitudinally and correlates them with objective functional measures of decline such as speech...

Read more

Sonoma Pharmaceuticals Celebrates 20 Years of Selling Wound Care Products in Europe and Announces New Distributor in Ukraine

July 9, 2024 7:30 AM

Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye, oral and nasal care, dermatological conditions, podiatry, and animal health care, today announces it is celebrating its 20th anniversary of selling wound care products in Europe.Sonoma is also proud to announce...

Read more

Zomedica Expands Global Reach Through Strategic Alliance with Leader Healthcare Group for Sales Expansion in Key International Markets

July 9, 2024 6:30 AM

ANN ARBOR, MI / ACCESSWIRE / July 9, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today announced the expansion of its sales reach to the Gulf Cooperation Council Countries, including UAE, Saudi Arabia, Qatar, Oman, Kuwait and Bahrain; along with Egypt and India. Leader Healthcare Group will be the...

Read more

New-Generation Slow-Dissolving Chlorine Tablets Provide Superior Pool Protection

July 9, 2024 4:00 AM

Introducing 3Chlorine New-Generation Chlorine Tablets to Provide Unparalleled Pool Maintenance and SanitationRANCHO MIRAGE, CA / ACCESSWIRE / July 9, 2024 / 3Chlorine, a leader in pool sanitation technology, is excited to announce the launch of its new generation Chlorine Tablets. This innovative product line includes three series: 3-inch tablets, 1-inch tablets, and fine granules, all designed to provide unparalleled pool maintenance and...

Read more

BioNxt Signs Master Services Agreement with International Contract Research, Development, and Manufacturing Organization

July 9, 2024 3:05 AM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is pleased to report that it has signed a master services agreement ("MSA") with a German-based international contract research, development, and manufacturing organization (the "CRDMO"). The MSA will serve as the foundation for BioNxt's future product development, particularly its pipeline of oral dissolvable ("ODF") drug formulations.With a head office in...

Read more

Best Rated San Antonio Plastic Surgeons for 2024 (Q1) Research Report Released by Doctor Marketing, MD

July 8, 2024 11:30 PM

San Antonio has some of the best plastic surgeons in the Southwest. The Review Growth Index™ (RGI™) by Doctor Marketing, MD™ has identified which San Antonio cosmetic practices made the list for the first quarter (Q1) of 2024. After compiling and analyzing data from over 93 medical practices and 5,532 online Google Reviews, the top rated Plastic Surgery and Cosmetic Surgery Clinics in San Antonio stand out for their patient satisfaction rating...

Read more

Newport Beach Plastic Surgeon Corrects Other Surgeons' Mistakes

July 8, 2024 10:35 PM

Everyone makes mistakes, but when it comes to plastic surgery, these mistakes can be especially devastating. Corrective plastic surgery addresses and fixes the errors made by previous surgeons, offering patients a chance to achieve their desired results. A specialist in revision surgery like Dr. Brandon Richland, MD, is adept at identifying what went wrong and how to effectively rectify it. By consulting with a board-certified, decades-plus...

Read more

Richland Aesthetics, Newport Beach's Luxury Med Spa

July 8, 2024 7:50 PM

Richland Aesthetics has quickly become Newport Beach's premier destination for innovative skincare and advanced medspa treatments, offering personalized plans tailored to each client's needs. Combining cutting-edge technology with exceptional attention to detail, they provide highly sought-after medical spa services such as Botox, HydraFacials, and PDO thread lifts, just to name a few. With extensive staff education and a passion for patient...

Read more

Moderna And Mitsubishi Tanabe Pharma Corporation Enter Joint Agreement to Promote Moderna’s mRNA Respiratory Vaccine Portfolio in Japan, Including COVID-19 Vaccines

July 8, 2024 7:00 PM

Moderna, Inc. (Nasdaq:MRNA) and Mitsubishi Tanabe Pharma Corporation today announced that the companies have entered into a joint agreement regarding the co-promotion of Moderna's mRNA respiratory vaccine portfolio in Japan, including Moderna's COVID-19 vaccine, Spikevax®.Under the agreement, Moderna will handle the manufacturing, sales, medical education and distribution of its mRNA respiratory vaccines. Both companies will engage in activities...

Read more

Theralase(R) Closes $CAN 775,000 in First Tranche of Non-Brokered Private Placement

July 8, 2024 5:15 PM

Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated Photo Dynamic Compounds ("PDCs") for the safe and effective destruction of various cancers, bacteria and viruses, is pleased to announce that it has successfully closed its first tranche of a Non-Brokered Private Placement ("NBPP") offering...

Read more

Issuance of New European & Australian Patents Bolster IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS) and Congenital Diarrheal Disorders (CDDs)

July 8, 2024 10:30 AM

Napo Pharmaceuticals (Napo), a Jaguar Health (NASDAQ:JAGX) (Jaguar) family company, today announced that the European Patent Office and IP Australia, the Australian patent office, have each issued a new patent to Napo. The European patent covers methods for treating SBS, bile acid diarrhea, and diarrhea associated with small intestine resection or gallbladder removal, in patients with an inhibitor of chloride-ion transport such as crofelemer,...

Read more

Au Pair USA Celebrates 35 Years of Connecting International Au Pairs with U.S. Host Families

July 8, 2024 9:00 AM

NEW YORK, NY / ACCESSWIRE / July 8, 2024 / Au Pair USA by InterExchange, the leading not-for-profit au pair agency, is proud to announce the program's 35th anniversary - a major milestone and a testament to the demand for international au pair childcare with a strong cultural component.Au Pair Agency Since its founding in 1989, Au Pair USA has strived to raise the bar for what families and au pairs can expect from this exciting cultural...

Read more

Just - Evotec Biologics Expands Tech Partnership for Biosimilars with Sandoz

July 8, 2024 8:20 AM

Just - Evotec Biologics expands partnership with Sandoz for development and commercial manufacturing of biosimilarsAdditional biosimilars potentially to be added to Sandoz development pipelineFurther guarantees for Sandoz long-term commercial supply securityHAMBURG, GERMANY and SEATTLE, WA / ACCESSWIRE / July 8, 2024 / Evotec SE (Frankfurt Stock Exchange:EVT)(NASDAQ:EVO) (MDAX/TecDAX , ISIN: DE0005664809) today announced that its biologics...

Read more

Mindbio Therapeutics CEO Issues Letter To Shareholders

July 8, 2024 8:20 AM

VANCOUVER, BC / ACCESSWIRE / July 8, 2024 / MindBio Therapeutics Corp. (CSE:MBIO)(Frankfurt:WF6), (the "Company" or "MindBio"), a leading biopharmaceutical company in psychiatric medicine development today issued a letter to shareholders from Justin Hanka, Co-Founder and Chief Executive Officer of MindBio.Dear Shareholders,We are delighted to provide an update on progress at MindBio, as we head into the second half of 2024 and continue with...

Read more

MMJ Shaking Up DEA Anti Marijuana Policy, Supreme Court Overturns Chevron Doctrine

July 8, 2024 6:00 AM

In a recent landmark decision, the U.S. Supreme Court overturned the 40-year-old Chevron doctrine, which historically granted federal agencies significant leeway in interpreting ambiguous statutes. This ruling has profound implications for regulatory bodies, including the Drug Enforcement Administration (DEA), and will affect ongoing cases such as MMJ BioPharma Cultivation's legal battle against the DEA. UNDERSTANDING CHEVRON DEFERENCEThe...

Read more